72. Pituitary ADH secretion disorder Clinical trials / Disease details
Clinical trials : 40 / Drugs : 28 - (DrugBank : 7) / Drug target genes : 5 - Drug target pathways : 9
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04789148 (ClinicalTrials.gov) | February 2022 | 5/3/2021 | Effects of Intranasal Oxytocin in Patients With Central Diabetes Insipidus | Effects of Intranasal Oxytocin in Patients With Central Diabetes Insipidus - A Pilot Study | Central Diabetes Insipidus | Drug: Oxytocin nasal spray | Elizabeth Austen Lawson | NULL | Not yet recruiting | 18 Years | 60 Years | All | 30 | Phase 1 | United States |